Cargando…

Survivors at risk: Hodgkin lymphoma survivors at high risk of second cancers

Amit Sud speaks to Sebastian Dennis-Beron, Commissioning Editor: Amit Sud is a clinical research fellow in Hematology at the Institute of Cancer Research, UK. He undertook his undergraduate medical training at the University of Manchester, gaining an honors degree. He completed his Masters in Medica...

Descripción completa

Detalles Bibliográficos
Autor principal: Sud, Amit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5985503/
https://www.ncbi.nlm.nih.gov/pubmed/29881540
http://dx.doi.org/10.2217/ijh-2017-0008
_version_ 1783328769376780288
author Sud, Amit
author_facet Sud, Amit
author_sort Sud, Amit
collection PubMed
description Amit Sud speaks to Sebastian Dennis-Beron, Commissioning Editor: Amit Sud is a clinical research fellow in Hematology at the Institute of Cancer Research, UK. He undertook his undergraduate medical training at the University of Manchester, gaining an honors degree. He completed his Masters in Medical Research at Manchester University, gaining a distinction. He continued his medical training in Manchester and London and started his specialization in Hematology in South West London. He was successful in obtaining a Cancer Research UK funded clinical research fellowship in Hematology under the supervision of Professor Richard Houlston at the Institute of Cancer Research. His current research focus is that of genetic susceptibility to Hodgkin lymphoma. He is a trainee member of the NCRI Lymphoma Clinical Studies Group.
format Online
Article
Text
id pubmed-5985503
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Future Medicine Ltd
record_format MEDLINE/PubMed
spelling pubmed-59855032018-06-05 Survivors at risk: Hodgkin lymphoma survivors at high risk of second cancers Sud, Amit Int J Hematol Oncol Interview Amit Sud speaks to Sebastian Dennis-Beron, Commissioning Editor: Amit Sud is a clinical research fellow in Hematology at the Institute of Cancer Research, UK. He undertook his undergraduate medical training at the University of Manchester, gaining an honors degree. He completed his Masters in Medical Research at Manchester University, gaining a distinction. He continued his medical training in Manchester and London and started his specialization in Hematology in South West London. He was successful in obtaining a Cancer Research UK funded clinical research fellowship in Hematology under the supervision of Professor Richard Houlston at the Institute of Cancer Research. His current research focus is that of genetic susceptibility to Hodgkin lymphoma. He is a trainee member of the NCRI Lymphoma Clinical Studies Group. Future Medicine Ltd 2017-06 2017-06-30 /pmc/articles/PMC5985503/ /pubmed/29881540 http://dx.doi.org/10.2217/ijh-2017-0008 Text en © 2017 Future Medicine Ltd
spellingShingle Interview
Sud, Amit
Survivors at risk: Hodgkin lymphoma survivors at high risk of second cancers
title Survivors at risk: Hodgkin lymphoma survivors at high risk of second cancers
title_full Survivors at risk: Hodgkin lymphoma survivors at high risk of second cancers
title_fullStr Survivors at risk: Hodgkin lymphoma survivors at high risk of second cancers
title_full_unstemmed Survivors at risk: Hodgkin lymphoma survivors at high risk of second cancers
title_short Survivors at risk: Hodgkin lymphoma survivors at high risk of second cancers
title_sort survivors at risk: hodgkin lymphoma survivors at high risk of second cancers
topic Interview
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5985503/
https://www.ncbi.nlm.nih.gov/pubmed/29881540
http://dx.doi.org/10.2217/ijh-2017-0008
work_keys_str_mv AT sudamit survivorsatriskhodgkinlymphomasurvivorsathighriskofsecondcancers